Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, December 9 at 2:00 PM ET

Register Free →

DENALI THERAPEUTICS INC.

UEI: WPDGJCK93HY6CAGE: 81T85

DENALI THERAPEUTICS INC. is a federal contractor, registered under UEI WPDGJCK93HY6 and CAGE code 81T85. It has been awarded $600,000 in federal contracts. Primary work spans Pharmaceutical Preparation Manufacturing. Top awarding agencies include Department Of Veterans Affairs.

Contact Information

Registration and classification details

Registration

UEI Code

WPDGJCK93HY6

CAGE Code

81T85

Entity Structure

Corporate Entity (Not Tax Exempt)

Established

N/A

Business Classifications

For Profit OrganizationManufacturer of Goods

NAICS Codes

325412Pharmaceutical Preparation Manufacturing(Primary)

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

AI Capability Profile

DENALI THERAPEUTICS INC. is a biopharmaceutical company based in South San Francisco, California, focused on the discovery, development, and translation of novel therapeutic candidates for unmet medical needs. The company’s core capabilities center on molecular biology, target identification, and pr...

DENALI THERAPEUTICS INC. is a biopharmaceutical company based in South San Francisco, California, focused on the discovery, development, and translation of novel therapeutic candidates for unmet medical needs. The company’s core capabilities center on molecular biology, target identification, and preclinical drug development, with expertise in protein engineering, pharmacokinetic modeling, and translational research pathways. Specializing in early-stage innovation, DENALI leverages proprietary platforms to advance biotherapeutics through IND-enabling studies, including in vitro and in vivo efficacy validation, toxicology assessment, and formulation development. Their technical differentiation lies in integrating structural biology with high-throughput screening to optimize lead candidates for CNS and immune-mediated disorders, emphasizing blood-brain barrier penetration and target specificity. No award history is available to infer specific agency engagements or contract patterns, and therefore no federal agency relationships can be confirmed based on the provided data. Similarly, no NAICS codes are associated with the company’s contract portfolio, preventing definitive classification of market verticals. As a result, industry focus cannot be determined from available records. DENALI THERAPEUTICS INC. operates as a privately held entity (Entity Structure: 2L) with no government certifications on record. The company maintains its primary presence in the biotech hub of South San Francisco, positioning itself within the broader California life sciences ecosystem. While its internal R&D focus suggests alignment with NIH and BARDA priorities in therapeutic innovation, no public procurement activity has been documented to substantiate direct government contracting relationships.

Key performance metrics

Award counts and award dollars by type, as prime and as subcontractor.

Awards Count

2

All time

Active

0

Currently performing

Completed

1

Past period of performance

Total Awards

All time

Contracts

Prime · all time

Subcontracts

Sub · all time

Grants

Prime · all time

Subgrants

Sub · all time

Award analytics

Awards by agency, industry, year, award type, size, and place of performance.

Awards by Agency
Awards by NAICS
Awards by Agency Over Time
Awards by Place of Performance

Compete with DENALI THERAPEUTICS INC.

Track the contractors you bid against, and the work they win

Award history, agency mix, and NAICS coverage for DENALI THERAPEUTICS INC.

AI-powered matching against your own capabilities and past performance

Teaming and subcontracting signals on every award

Automated alerts when a competitor wins in your market

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS

Open opportunities in DENALI THERAPEUTICS INC.'s top NAICS codes and agencies

NAICS: 325412
New
Federal
6505--766-27-1-400-0021 -Charleston CMOP CALCIUM 500MG/VIT D 500UNIT CHEW TAB 90CT -(VA-27-00014312)
Solicitation # 36C77027Q0013
The Department of Veterans Affairs, through the National CMOP Office, is seeking the procurement of 3,200 units of Calcium 500mg/Vitamin D 500unit chewable tablets (90ct) for the Charleston CMOP located in Ladson, South Carolina. This requirement is a Total Small Business Set-Aside under NAICS code 325412. The contract specifies a delivery schedule of 800 units per month over a four-month period, with the initial delivery due 10 days after award. All products must be shippable via the United States Postal Service and must have an expiration date of at least 12 months from the date of delivery. To be deemed compliant, offerors must provide a distinct eleven-digit National Drug Code (NDC) and maintain an FDA therapeutic equivalence rating of A. Mandatory documentation includes state wholesale distributor licensure verifying compliance with the Drug Supply Chain Security Act, a Buy American Act Certificate specifying the country of origin, and OEM authorized dealer or reseller documentation to prevent gray market items. Technical requirements mandate that all products include linear bar code labeling conforming to GS1-128 or HIBCC standards, meeting ANSI/ISO/IEC Quality Grade C or better. Packages under 500 count must feature safety or child-proof caps.
National Cmop Office (36C770)

POSTED

about 9 hours ago

DEADLINE

in 7 days
View Details
NAICS: 325412
New
Federal
Charleston CMOP CARBOXYMETHYLCELLULOSE NA 0.25% OPH SOLN 15ML
Solicitation # 36C77027Q0019
The Department of Veterans Affairs, through the National CMOP Office, is conducting a sources sought market research effort under solicitation 36C77027Q0019 for Carboxymethylcellulose NA 0.25% Ophthalmic Solution 15ML. This effort is intended to identify capable vendors for the Charleston CMOP in South Carolina. Interested parties must submit responses via email to Sarah Fry, providing their business size, classification, and UEI number, along with a confirmation of whether they possess direct Original Equipment Manufacturer (OEM) documentation to prevent gray market and counterfeit items. Technical requirements specify that products must have an FDA therapeutic equivalence code of A, unless all drugs in the family group are B rated, and must comply with the Drug Supply Chain Security Act. Deliveries are expected 10 days after receipt of order, with pharmaceutical expiration dates required to be at least 12 months from the delivery date. Packaging must adhere to strict standards, including the use of child-proof caps for packages under 500 count and specific bottle dimensions. Furthermore, all products must feature unit-of-use bar coding conforming to GS1-128, HIBCC, or HIBC standards with a minimum of ANSI/ISO/IEC Quality Grade C. All shipments must include detailed packing slips containing the VA purchase order and obligation numbers, NDC, and product line-item numbers.
National Cmop Office (36C770)

POSTED

about 9 hours ago

DEADLINE

in 7 days
View Details